Recently, measurement of RNA at single cell resolution has yielded surprising insights. Methods for single-cell RNA sequencing (scRNA-seq) have received considerable attention, but the broad reliability of single cell methods and the factors governing their performance are still poorly known. Here, we conducted a large-scale control experiment to assess the transfer function of three scRNA-seq methods and factors modulating the function. All three methods detected greater than 70% of the expected number of genes and had a 50% probability of detecting genes with abundance greater than 2 to 4 molecules.
. Uniquely aligned reads were assigned to GENCODE18 gene annotations using HTSeq and htseq-counts 18 and then were depth normalized 19 . Ribosomal genes and genes with short isoforms (<300 nucleotides) were excluded because of differences in sequencing protocols across groups ( Figure 1A ), leaving 42,855 genes for analysis. (We use "gene" to match GENCODE18 gene ids, a set that includes both coding-and non-coding RNA.) To avoid artifacts caused by alignment or quantification ambiguities, we generated a stringently filtered gene list containing 10,039 genes to which reads can be uniquely assigned and referred to these genes as "computationally unambiguous" throughout (Table S2) . Reference RNA were aligned and quantified with RSEM (RNA-seq by Expectation-Maximization) 20 . Estimated abundances were concordant with publicly available PrimePCR measurements and with poly-A RNA sequencing measurements ( Figure S1 , SEQC/MAQC-III Consortium, 2014, GEO accession numbers: GPL18522, GSM1362002-GSM1362029,
GSM1361974-GSM1362001 21
). The mass of targeted input RNA in diluted replicates was estimated as in Brennecke et al. 2 and was used to calculate, for each gene, the expected number of input molecules in a diluted replicate. aRNA selectively targeted poly-adenylated (poly-A) mRNA ( Figure 1A ). We calculated the expected number of input poly-A molecules using publicly available bulk HBR sequencing measurements. See Methods for further details.
On average, replicates were sequenced at a depth of 22.0 ± 9.6 million reads (± standard deviation or Sd.). 1.5 ± 5.3% of reads were discarded due to primer contamination. 89.3 ± 10.6% of retained reads aligned to the genome, 77.6 ± 11.2% uniquely ( Figure 1C ). To examine the coverage distribution of each method, we quantified the frequency of mapped reads over several genomic regions of interest (Table 1) . This distribution differed for the three single-cell amplification methods. The majority of aligned reads for aRNA dilution replicates originated from non-mitochondrial exons (excluding rRNA), a substantially larger proportion than that recovered by SmartSeq Plus or NuGen. rRNA genes, pseudogenes and repeats encoded by the nuclear genome comprised a small fraction of reads in all amplified libraries (average ± SD: 0.67 ± 0.65%). rRNA and mRNA encoded by the mitochondrial genome (2 genes and 13 genes, respectively) constituted a substantial percentage of reads (average ± SD: 16.5 ± 8.4%). Mitochondrial recovery differed substantially across methods. This difference may translate into a method-specific effect on depth normalization and for this reason mitochondrial genes have been excluded from the subsequent analyses. The distribution of reads across genomic features also differed substantially across replicates for aRNA and NuGen (Table 1) .
Gene detection sensitivity
We calculated the number of detected genes as a measure of detection sensitivity ( Figure 2A ). All and Tables S3-S4 for details.) All methods had a 50% probability of gene detection at ~2-4 expected input molecules, controlling for the remaining covariates ( Figure 2B , Table   S5 ). We calculated a molecular recovery rate as the predicted probability that a gene with 1 expected input molecule will be detected, scaled by the probability that at least one molecule of such a gene will be in a diluted replicate. Molecular recovery rates were greater than 0.25 for all methods (95% prediction interval: aRNA (0.262, 0.279), SmartSeq Plus (0.534, 0.558), NuGen (0.315, 0.339)). With respect to poly-A RNA, aRNA recovery rate was (0.320, 0.349).
Despite the small number of total (targeted) RNA molecules in a single 10 pg. dilution replicate (estimated here to be ~300,000 molecules), sequencing depth had a highly significant effect on gene detection (Table S3 ). Figure 2C shows the odds ratio of increasing sequencing depth by 500,000 reads.
The odds ratio is the relative odds of event occurrence at two values of a variate, controlling for all other A small fraction of computationally unambiguous genes had poor fit by the logistic model (0.30 ± 0.14%; see Table S6 for a list of outliers and Methods for details). Each outlier was categorized as "detected" if the gene was unexpectedly observed and "undetected" if it was unexpectedly missing.
Nearly all identified outliers (16/17) were method-specific. A larger proportion of computationally ambiguous genes were poorly fit by the model (3.21 ± 0.23 %, Table S6 ) with a sizable fraction (19.81 ± 2.90%) that fit poorly for all methods. These outlier genes had significantly lower fraction of the gene body that could be aligned uniquely than background genes ( Figure 2F ; Wilcoxon rank sum two-way test, p<0.05). This was the case for both detected and undetected outliers, indicating that alignment ambiguities likely generate both false positives and false negatives. Outliers also significantly differed from background in the fraction of the gene body that overlaps with another gene annotation, with lower overlap among detected outliers and greater overlap among undetected outliers ( Figure 2G ). Plus showed an intermediate degree of bias. Segregated by expression levels, we found preferential recovery of the 5' and the 3' gene ends for low abundance genes and preferential 3' coverage for high abundance genes ( Figure 2J ).
Precision
We next consider the similarity of measurements across dilution replicates, within methods and across methods. Though we cannot quantitatively compare measurement precision across methods (see Figure 1A) , the results will be applicable to experimental design and analysis for each method. The average within experimental group pairwise correlation coefficient (± Sd.) was 0.37 ± 0.07 (Kendall) and 0.51 ± 0.09 (Pearson, log 10 counts) for 10 pg. replicates and 0.64 ± 0.06 (Kendall) and 0.79 ± 0.06 (Pearson, log 10 counts) for 100 pg. replicates ( Figure 3A ; zeros treated as missing values).
To describe the dependence of precision on expression level, we performed least-squares regression of the empirical standard deviation on the empirical mean (both variables log-transformed to satisfy the assumption of residual normality) for 10 pg. experimental groups with sample size >5. The Table S7 . We recommend that the expression values of these gene models should be interpreted with caution.
Separate principal components analysis (PCA) of each HBR and UHR for 10 pg. dilution data demonstrated that average displacement between single cell and bulk measurements predominate over differences between single cell methods ( Figure 3G-H) ; however, there were clear differences across methods in the multivariate covariance structure of experimental variation. Differences across methods were also apparent for 100 pg. dilution replicates ( Figure 3I -J), and, though these measurements were more similar to bulk measurements, differences between dilution replicates and bulk measurements persisted. We note that average displacement between single cell and bulk measurements represent both a bias component from utilizing a master dilution mix (see above) and technical bias. We repeated PCA on a subset of genes with greater than 18.5 expected input molecules (expected probability of detection for "typical" gene > 0.9 for all methods). On highly abundant genes, dilution replicates were substantially more similar to bulk measurements ( Figure 3K -N) and differences across methods were substantially smaller. However, in all cases, the within method pattern of covariation (direction of ellipses) and the bias dispersal around the bulk expected value (position of the centroid of the ellipses) differed for both source RNA and individual methods.
Accuracy
We calculated pairwise correlation coefficients of dilution replicates with bulk as a metric of overall accuracy ( Figure 4A ). For this and the below, only non-zero gene counts were considered in order to focus on quantitation rather than sensitivity. 10 pg. dilution replicates demonstrated an average pairwise correlation with reference of 0.42 ± 0.01 (Kendall) and 0.55 ± 0.01 (Pearson, log 10 counts). 100
pg. replicates showed greater similarity with reference (0.57 ± 0.01 (Kendall) and 0.72 ± 0.01 (Pearson, log 10 counts). Correlation with reference had a modest association with percent unique alignment ( Figure   4B -C).
To assess the accuracy of individual gene estimates, we calculated the fold deviation of normalized read counts with respect to bulk HBR or UHR measurements ( Figure 4D-F, Methods) . For all methods and input amounts, the median fold deviation was less than 1 but a subset of genes was extensively overestimated. Overestimated genes (top 5% fold-deviation) were substantially longer than remaining genes and more frequently contained an internal A-hexamer ( Figure 4G -J). For NuGen and SmartSeq Plus, these genes also had lower GC content and weaker local secondary structure than remaining genes. Underestimated genes (bottom 5% fold-deviation) demonstrated the opposite tendencies: compared to background genes, they were shorter, less frequently contained internal Ahexamers, had higher GC content and stronger secondary structure than background, as might be expected ( Figure 4G-J) . Overall, aRNA demonstrated less systematic bias than NuGen or SmartSeq Plus. Highly inaccurate genes (top or bottom 1% fold-deviation) are catalogued in Table S8 .
Smoothed density scatter plots demonstrated method-specific transfer functions between the expected number of input molecules and the number of read counts in an individual replicate ( Figure 4K -M). This relationship was roughly linear at expression levels greater than ~5-10 expected input molecules up to at least ~600 input molecules, the highest expression level examined for 10 pg. replicates, giving a linear dynamic range of at least 100-fold. At low to mid expression levels measurements were frequently underestimated expanding the apparent range of measured abundances, particularly for aRNA and NuGen ( Figure 4N -P).
Protocol variations
We evaluated the effects of several protocol variations on measurement quality ( Table 2 ). The aRNA protocol used for the primary analysis includes cDNA purification before initial amplification, and 3 rounds of IVT amplification followed by dilution of amplified cDNA before library preparation ( Figure 1B ).
Elimination of initial cDNA purification significantly improved sensitivity and accuracy, as did reduction to two rounds of IVT amplification and elimination of dilution prior to library generation ( Table 2 ). An optimized protocol incorporating both changes, demonstrated substantial improvements in the number of detected genes and pairwise correlation with the bulk (Table 2 ).
The addition of ERCC spike-in transcripts provides an internal control 22 , but it raises the concern that addition of synthetic RNA to a sample may decrease biological sensitivity. We found no significant difference in sensitivity, precision or accuracy across matched dilution replicates with and without the addition of ERCCs (Table 2 ) up to the spike-in level of 2.7% of reads. Individual ERCC transcripts were found to be problematic, consistently inaccurate, for SmartSeq Plus and aRNA in a method specific manner ( Figure S2 ).
Strand-specific RNA sequencing may improve detection sensitivity and reduce false positive detection. Stranded quantification of aRNA replicates detected slightly fewer genes than non-stranded quantification; however, it also detected significantly fewer genes that were not observed in the bulk, and genes that were detected only by stranded quantification were supported by significantly more reads than genes detected only by non-stranded quantification ( Table 2) .
Discussion
In light of these results, we briefly discuss a few topics related to experimental planning, method optimization and data analysis.
Though the goal of this study and our experimental design is not meant to select "the best method", some results may be helpful in selecting an appropriate method for a particular project. The enriched coverage of exons in aRNA may be beneficial for studies of mRNA, and the retention of transcript strand information is unique to aRNA at this point. SmartSeq Plus and C1 microfluidic device generates reproducible replicates and high detection sensitivity, presumably due to more uniform liquid handling and retention of material due to lack of vessel transfer. The uniformity of coverage provided by NuGen ( Figure 2H -I) may be beneficial studies of isoform use and splicing. We note that, in our hands,
NuGen reactions were inconsistent and we had repeated amplification failures, or amplification of nontemplate directed products with this method, especially at the 10 pg level where the method appears to be reaching the limits of it sensitivity.
In selecting sequencing depth, there is a trade-off between gene detection sensitivity and cost.
Typically, a small number of genes comprise the bulk of RNA molecules in a transcriptome. Sequencing at low depths should be sufficient to reproducibly detect and quantify these abundant genes; however, the majority of genes in a typical transcriptome are at low abundance. Because of this, the number of genes detected in the mixtures of RNAs used here depends heavily on sequencing depth ( Figure 2C ). The dynamic range limit due to sequencing depth is will be a function of the relative frequency distribution, which will vary for an actual single cell. Our results suggest that increasing the number of reads per cell may produce richer transcriptome measurements and should be considered carefully in the context of a specific experimental plan.
Missing values due to lack of sensitivity and the presence of large valued outliers may cause complications for depth normalization methods. Large variation across samples and substantial differences across methods in the fraction of reads assigned to mitochondrial RNA (Table 1) will propagate to sample and method differences in relative read counts. More generally, we observed large variation in the distribution of reads across broad genome annotation classes (Table 1) . Because each genomic annotation class accounted for a substantial number of reads and input molecules, the observed differences across methods, and within methods, cannot be simply explained by sampling error. Similarly, variation across samples in the number of detected genes cannot be easily explained by dilution ( Figure   2A ). This behavior might be explained by global differences in reaction efficiencies across samples, as suggested previously 25 ; however, the experimental sources of such differences in a controlled experiment are unclear. We found certain subsets of genes to be problematic for gene detection, accuracy, and precision, in a method-specific manner (Table S6-S8) . We recommend that genes on these lists be treated with caution, filtered before analysis or interpreted with care. We similarly found several ERCC spike-in transcripts to be problematic ( Figure S2 ), and recommend selecting a subset of reliable ERCC transcripts for use as reference measurements.
Some scRNA-seq quantification challenges might be reduced through further experimental optimizations, for example by increasing detection sensitivity and reducing amplification biases.
Eliminating the initial cDNA purification, reducing the extent of amplification required, and limiting sample dilution may be productive avenues, as suggested by our data. Methods to experimentally deplete highly abundant and variably recovered mitochondrial RNA, if not of experimental interest, may also be of use.
Single cell RNA measurement methods have become increasingly robust and automated systems have made the technique broadly more accessible and efficient. All methods examined here demonstrated good gene detection and a linear relationship between input molecular abundances and measured expression levels at mid-to high-expression levels or greater than ~5-10 input molecules. This corresponds to ~4,000-8,000 reliably measured genes for the reference transcriptomes examined here.
We propose that single cell RNA measurements have come of age and this level of resolution for gene expression measurements has and will continue to facilitate biological discovery.
Methods

Experimental design
Each collaborating center obtained reference RNA with the same lot number for Universal Human
Reference ( Samples for each source RNA were prepared in single batches. After amplification, cDNA from the entire C1 96-well plate was quantified using picogreen. C1 chips with an average yield of less than 3 nanograms were discarded. The top 15 reactor wells by cDNA concentration were selected as representative 10 pg. samples for sequencing library preparation. Another 50 wells were selected by the same criteria. These were pooled in sets of 10, generating 5 100 pg. samples for each HBR and UHR. All samples for a given source were prepared in a single sequencing library preparation batch using Nextera XT C1 protocol.
NuGen: HBR samples were prepared in a single batch using amplification protocol 1, generating 4 10 pg. and 4 100 pg. amplified replicates. UHR samples were prepared in two batches, using either amplification protocol 1 or 2, generating 15 10 pg. and 11 100 pg. samples (see Table S1 ). A single sequencing library preparation was performed for each batch of samples using either Lucigen NxSeq or NuGen Ovation Rapid protocol (see Table S1 ).
aRNA: Amplification was performed as previously described 26 . HBR samples were prepared in 4
batches from separate dilutions of reference RNA, generating 19 10 pg. and 3 100 pg. amplified
replicates. ERCC spike-ins were added to 5 of the 10 pg. replicates before amplification at a dilution of 4,000,000x from stock. UHR samples were diluted and amplified in 2 batches from separate dilutions of reference RNA, generating 12 10 pg. and 7 100 pg. amplified replicates. (Table S1) . A single sequencing library preparation was performed using Illumina TruSeq Stranded mRNA protocol modified to begin with amplified aRNA. A small numbers of reads were assigned to ERCC transcripts in replicates from the batch where ERCCs had been added that did not have spike-ins added (average of 0.5% of the number of reads assigned in spiked samples). 18 additional HBR 10 pg. replicates were amplified using aRNA for protocol optimization experiments (see Table S9 ). These samples were treated separately and were excluded from primary analysis.
Bulk UHR and HBR:
For each reference RNA, three sequencing libraries were generated from bulk material at the same laboratory as the SmartSeq Plus replicates. Cytoplasmic and mitochondrial ribosomal RNA (rRNA) were depleted using Ribo-Zero Gold as part of Illumina TruSeq Stranded Total RNA protocol. Samples were sequenced on Illumina HiSeq 2000. We also accessed publicly available bulk sequencing of HBR and UHR generated using poly-A selected RNA generated using standard Illumina mRNA-Seq protocol and sequenced on Illumina HiSeq 2000 using 100 bp. paired-end reads.
(SEQC/MAQC-III Consortium, 2014,GEO accession numbers: GSM1362002-GSM1362029 (HBR),
GSM1361974-GSM1362001 (UHR), downloaded in May 2015
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.) These samples were generated as part of a larger experiment to evaluate bulk RNA sequencing where poly-A sequencing was performed at seven sites. For each HBR and UHR, four replicate libraries generated at the NYG site were used.
Sequenced read data for each source were pooled. We additionally used publicly available PrimePCR measurements generated by the SEQC/MAQC-III Consortium using UHR and HBR RNA (SEQC/MAQC-III Consortium, 2014, GEO accession number: GPL18522, downloaded in Feb. 2015 21 ) to evaluate our reference gene abundance estimates.
Because of differences in experimental design, direct comparison across methods of precision and the effect of input RNA abundance is difficult. For example, input RNA amount as a factor have different meanings for the different amplification methods: for SmartSeq Plus, because 100pg samples were constructed by pooling 10 pg. samples after cDNA amplification, any resulting effects involve library construction, while for aRNA and NuGen resulting effects reflect both cDNA amplification steps and library steps.
Alignment and quantification
Low confidence nucleotides (with Phred score less than 20) were treated as unknown and replaced with Ns. Unknown nucleotides (Ns) at the ends of reads were trimmed. Poly-A and methodspecific adapter sequences were trimmed from the 3' end of reads using in-house software 27 . Reads were aligned to the human reference genome, build hg19, and to ERCC spike-in transcript sequences using STAR 17 . We retained reads that aligned to at least 40% (paired-end) or 60% (single-end) of trimmed length or 30bp, whichever was greater. In addition, we discarded reads with greater than 30% mismatched positions in trimmed length. Uniquely aligned reads were assigned to GENCODE18 gene annotations and to ERCC transcripts Using HTSeq and htseq-counts. Reads overlapping multiple annotations were assigned to a single gene or discarded using the intersection non-empty method 18 . We normalized raw read counts for differences in sequencing depth using size-factors estimated by the method proposed by Anders and Huber and implemented in DESeq
Excluded and ambiguous genes, below. aRNA sequenced data retained RNA strand information, but we did not use this information in quantification so that that all methods were analyzed consistently. For protocol optimization analysis (Table 2) , aRNA samples were re-quantified using strand information where applicable. Each method demonstrated different dependence of read counts on gene length ( Figure 2H ), so no single length normalization procedure was appropriate, hence the analyses were completed without length normalization.
To estimate input RNA abundances, raw sequencing data from all three ribosome-depleted bulk HBR or UHR replicates were pooled resulting in a single sample for each HBR and UHR with sequencing depth of ~400 million reads. 20, 28 . Poly-A tails were not added to transcripts. RSEM gene abundances were normalized to transcripts per million (TPM). 50.4% and 51.1% of reads aligned to genes for HBR and UHR, respectively.
We validated the robustness of the RSEM abundance estimates by comparing them to estimates generated using two additional algorithms. First, we used HTSeq and htseq-counts 18 in the intersection non-empty mode as described above. This method makes few assumptions about the distribution of sequencing reads along transcripts. Second, we used a modified version of Maxcounts 29 , a method designed to be robust to differences in sequencing protocol and each gene was assigned the 95%ile depth of coverage value across covered exons. For both HTSeq and Maxcounts, quantification was strand-specific and estimates were normalized to reads per million (RPM). Counts were also compared to PrimePCR measurements (see Experimental design). To compute gene abundance estimates using PrimePCR, we removed undetectable genes (C T >35, based on a C T of 35 for one DNA molecule 21 ) and then subtracted 35 from each gene's C T value to generate log 2 number of molecules, which were then converted to log 10 units. Genes with multiple reported C T measurements were removed, leaving 11,788
(UHR) and 11,572 (HBR) gene measurements for analysis. Pairwise scatter plots and correlations can be found in Figure S1 . All quantification algorithms provide similar estimates. We used RSEM quantification throughout because this method provides isoform expression level estimates, which allow more finetuned estimates of gene characteristics (such as GC content and length).
Ribosomal and mitochondrial RNA were depleted from bulk HBR and UHR samples (see
Experimental Design).
We compared estimated RNA abundances based on these samples to abundance based on samples generated using poly-A RNA to determine whether the method of RNA selection substantively affected abundance estimates. Expression estimates were similar across library preparation methods and the library generated with ribosomal and mitochondrial depletion demonstrated the greatest similarity with qPCR measurements ( Figure S1B ). RSEM expression level estimates based on ribosomal and mitochondrial RNA depleted samples were used as "truth" throughout.
Excluded and unambiguous genes
We excluded ribosomal genes, genes with short isoforms, and genes on the mitochondrial chromosome, as described in the main text. Inferences made by bioinformatics methods may affect sensitivity, precision, and quantification accuracy for any individual gene. We identified a stringent set of genes to which reads could be uniquely aligned, in order to focus on sensitivity, precision and accuracy of the molecular measurements. Identified genes did not overlap in genomic positions with exons from any other annotated gene on either strand and could be aligned to uniquely across the entire gene. As a measure of mappability we used the GENCODE CRG Alignability track for reference genome hg19, generated by the ENCODE project and downloaded as a bigwig file from the UCSC Genome Browser on Sept. 23 2014
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. This track contains sliding windows of k-mers and a record of how many locations in the genome each k-mer aligns using the GEM aligner allowing up to two mismatches. We used k equal to 50 nucleotides because the minimum read length in this study was 50 base pairs. Genes where all sliding windows align to only one location were considered uniquely alignable.
Expected number of molecules in diluted replicate
We estimated the expected number of molecules in a diluted replicate in three steps. First, we estimated the fraction of total input RNA that was targeted for cDNA synthesis and used this to find the mass of targeted RNA. Second, we converted this mass to a total number of input molecules using the average transcript length for each HBR and UHR. Third, we converted gene relative expression levels to expected numbers of molecules in a diluted replicate.
To estimate the mass of RNA targeted for cDNA synthesis, we followed a previously described 
Genomic distribution of sequenced reads
Genomic regions were assigned to eight categories hierarchically so that each region was assigned to only one category and so that each read was greedily categorized in the following order:
rRNA exon, rRNA repeat, exon (excluding rRNA), intron, flank, intergeneic. Regions were defined based on the following annotations. Exons and introns were assigned based on GENCODE18 annotations.
Flanks were assigned to 5 kilobases up-and down-stream from gene terminals. rRNA refers to GENCODE18 annotations with "rRNA" as the gene_type, which includes 5S pseudogenes. rRNA repeat refers to RepeatMasker annotations for the rRNA class of repeat. RepeatMasker annotations for reference genome hg19 were downloaded from UCSC table browser as a gtf file from the UCSC genome browser on June 23, 2015. Remaining regions were classified as intergenic. Primary alignments for all reads, including multimapping reads, were assigned to these regions using htseq-counts 31 . The STAR aligner assigns a single primary alignment to each read, with multi-mapping reads assigned the alignment with the best alignment score, if only one such alignment exists, or a randomly selected alignment from the set of best alignments. (Multi-mapping reads were included for this analysis because many rRNA regions demonstrate substantial similarity such that it was difficult to uniquely align reads to these regions.) Haplotype and random chromosomes were excluded.
Number of detected genes
Genes not observed in the bulk were ignored. The expected number of genes in a diluted replicate was calculated as follows. We assumed that the number of molecules in a tube for a given gene are Poisson distributed with mean equal to the expected number of input molecules and that genes are independent. The presence or absence of a given gene follows a Bernoulli distribution, with the probability of success equal to the probability that at least one molecule for the gene is in the diluted replicate. The number of genes in a diluted replicate is then drawn from a Poisson-Binomial distribution.
We used the R package poibin to find a 95% CI for the expected number of genes in a diluted replicate.
We performed simulations of the dilution experiment to check robustness of the result to violation of the independence assumption. Simulation results matched theoretical results (data not shown). We performed this analysis both assuming that total RNA was targeted for capture and assuming mRNA was targeted for capture (see Expected number of molecules in diluted replicates, above). Because UHR aRNA dilution replicates did not contain ERCC spike-ins, we could only estimate mRNA expectation for HBR.
Gene traits
We compiled a set of gene characteristics for use in bias exploration. Traits calculated include GC content and length, both known sources of bias for bulk RNA sequencing 32 . Poly-T priming was used by aRNA and SmartSeq Plus and may introduce a bias for genes with internal stretches of adenosines, and so we also computed the presence or absence of an internal A-hexamer (6 or more sequential As).
RNA secondary structure may hinder biochemical reactions and we assigned a score for the average strength of local secondary structure. To do this, we calculated the minimum free energy predicted by Vienna RNAFold (version 1.7.2) 33 for 100 nucleotide-sliding windows along the length of each isoform (step size of 1 nucleotide) and reported the average across all windows. All traits are calculated based on GENCODE18 annotated isoforms. Genes were assigned the average of isoform traits, weighted by the relative expression level of isoforms estimated by RSEM quantification of bulk HBR or UHR. We also calculated two metrics of bioinformatics complexity for each gene. As a measure of alignment complexity, we calculated the fraction of 50 base pair windows that were reported to be uniquely alignable in the GENCODE CRG Alignability track 34 (see Excluded and unambiguous genes, above). As a measure of quantification complexity, we calculated the fraction of the gene body that overlaps with another annotation on either strand. Both of these metrics were calculated over the union of exons for each gene.
Detection logistic regression
For model fitting, we used computationally unambiguous genes (see Excluded and unambiguous genes, above) that were observed in bulk HBR or UHR. Genes within the upper or lower 2.5%ile value for any biophysical trait were excluded so that covariate ranges were well sampled. After filtering, 5,645
genes were included in analysis. The analysis was performed on 10 pg. dilution replicates. 100 pg.
dilution replicates were not included because of the small sample size of these groups and because of differences between groups in how these dilution replicates were generated (see Figure 1A and
Experimental design). A single model was fit containing both HBR and UHR dilution replicates, in order to
increase sample size and simplify analysis. A random 90% of the data were used in model development and fitting, with the remaining 10% used to assess model fit. Final sample size for model development was 323,194 observations and for validation it was 45,486 observations.
To determine the best parametric form for each independent variable we followed the multivariate fractional polynomial method. In brief, this method (developed by Royston & Altman, 1994) searches a small range of possible polynomial functions of each independent variable to identify the transform that results in the best model, defined as having the largest log-likelihood. Both one-and two-term transforms can be tested. Before selection of a "best" transform, fit models using transformed variables are compared to the linear case (and to each other, if both a one-and two-term transformation are considered) using a likelihood ratio test (here the null hypothesis of no difference in fit was rejected at p<0.001). See Hosmer et al. 35 for more details. In the final model, amplification method was encoded as dummy variables so that methodspecific coefficients were found for all independent covariates, with the exception of sequencing depth.
We fit a single coefficient for depth across all methods to increase the covariate range. The final model was fit excluding 17 large influence genes (having Cook's Distance >0.001 for at least two observations in each of at least two methods) using R built-in glm function with family (error model) set to binomial 37 . The final model can be found in Table S3 . Model fit was assessed using normalized Chi-Square (proposed by Osius and Rojek) and normalized Sum-of-Squares goodness-of-fit statistics, evaluated on a random 10% of the data excluded from model development (Table S4 , and see Hosmer et al. for details). To assess the benefit of including biophysical and sample covariates, in addition to the expected number of input molecules, we calculated the area under the receiver operating characteristic curve (AUC) for classification using the model, and separately for classification based on the expected number of input molecules alone. AUC provides a measure of the probability that the classifier will assign a higher score to a randomly selected detected gene than a randomly selected undetected gene. AUC average and standard deviations were calculated over 10,000 bootstrap replicates. To determine whether the model was sensitive to read length or paired end status, we calculated fit statistics for data truncated in silico to 50 base pair single-end reads (Table S4) . We additionally tested extension of model to ERCC spike-in molecules (using SmartSeq Plus and aRNA 10 pg. dilution replicates containing spike-ins) and to dilution samples beginning with 100 pg. input RNA (Table S4 ). For these additional validations, a random 5,000
observations were used to calculate fit statistics. For tests of extension to 100 pg. data, SmartSeq Plus samples were excluded because these samples were not generated using 100 pg. input RNA for cDNA generation and amplification, but by pooling ten 10 pg. diluted replicates before sequencing library preparation, and so were not appropriate for the modeled process. In all cases, validation statistics were calculated based on predictions for genes within covariate ranges used in model fitting and excluding 17 identified large influence genes. For ERCC samples, this meant that four transcripts shorter than 300 nt.
were excluded. Also, because the ERCC molecules span a 10 6 range while transcriptomes at a single-cell level span ~10 3 range, 2.5%ile trimming based on input molecules means that only 50 out 92 transcripts were used. While the expected number of input molecules is a very good predictor of gene detection, addition of the remaining independent variables improved prediction (Table S4 ). All additional independent covariates also contributed significantly to the model. The model was not sensitive to readlength or paired-end status: it fit data truncated in silico to 50 base-pair single-end reads well (Table S4) .
The model did not fit ERCC or 100 pg. dilution replicates well (Normalized Chi-square goodness-of-fit test p < 0.05); however, it still improved prediction accuracy in these cases compared to using the number of input molecules alone for prediction (Table S4) .
When examining the effect of the number of input molecules on the probability of gene detection, 
Sensitivity outliers
We calculated the squared deviance residual for each observation as a measure of fit, using the logistic model described above. The sum of squared deviance residuals is equivalent to the likelihood ratio test statistic comparing the saturated model with respect to the fitted model, and the sum of squared deviance for a subset of observations can be considered the contribution of this set of observations to overall model fit. To find method-specific problematic genes, we calculated the average squared deviance residual for each gene over all samples for each method separately. For each method, we classified genes with average squared deviance residual larger than 4 as outliers. We repeated outlier identification for computationally ambiguous genes within the range of covariates used in model fitting (n=28,270).
Coverage using Bioconductor libraries GenomicRanges and Rsamtools [38] [39] [40] . Coverage was calculated based on uniquely aligned reads only. Only computationally unambiguous genes were used. Additionally, only genes with a single annotated isoform were used in this analysis.
We To characterize measurement precision, we performed least-squares regression of the empirical standard deviation on the empirical mean. We used computationally unambiguous genes to fit these models. Additionally, we included only genes with >95% probability of presence in a diluted replicate, excluded gene detection outliers and trimmed the upper and lower 2.5%ile by mean value for model fitting. Both the average and standard deviation were log-transformed for normality of residuals. After all filtering, at least 1,100 genes were used to fit the model: log 10 (standard deviation) = a + b * log 10 (mean).
Sample sizes ranged from 1,149-1,269 genes. A separate model was fit for each experimental group.
Because 100 pg. experimental groups have small sample sizes (for most, n<=5) and so provide unstable estimates of variance due to missing values, we performed this analysis on 10 pg. groups only. The NuGen HBR 10 pg. sample size is also quite small (n=4) and was excluded.
To characterize biases in experimental variation we selected a subset of genes where empirical standard deviation was not well predicted by the mean, meaning genes with standardized residuals outside 90% confidence interval of predicted value (assuming a T-distribution with n-3 degrees of freedom for standardized residuals), and a set of "typical" genes, where the gene variance is well predicted by the mean. Typical genes were defined as possessing standardized residuals inside an 80% confidence interval of predicted value. For enrichment tests of GC-content, length, and secondary structure, we calculated the Hodges-Lehmann estimate of difference in location to provide an estimate of the magnitude of in location between test and background gene. This metric estimates the median difference between the two groups.
We identified outliers with unexpectedly high or low experimental variation as genes with 99.3%
confidence interval of predicted value. We considered computationally unambiguous genes, and also extended the analysis to computationally ambiguous genes, excluding those with mean expression outside the range used in model fitting.
Principal components analysis was performed on sample covariance matrix calculated using zero-corrected log-transformed read counts for computationally unambiguous genes with non-zero counts in at least on sample and using the R prcomp function. Each PCA included the appropriate bulk HBR or UHR. RSEM-estimated relative frequencies were normalized to the same scale as the diluted replicates using the DESeq method for estimating size factors, as described above. Bivariate normal 95%
confidence ellipses were calculated for each experimental group using the R dataEllipse function from the car package 41 .
Accuracy
Sample sizes (number of genes) for analysis in Figure 4D -N, given filtering described in plot legend, were the following: HBR: n=1,339 (10 pg.) and 2,797 (100 pg.); UHR: n=1,243 (10 pg.) and 2,614 (100 pg.) As stated, in evaluation of gene measurements in individual dilution measurements genes with zero read counts were excluded. For evaluation of average gene measurements, zero values in individual replicates were retained. RSEM-estimated relative frequencies were treated as true relative expression values for each gene. These were normalized to the same scale as the diluted replicates using the DESeq method for estimating size factors, as described above. Wide boxes in boxplots of fold deviation in Figure 4D -F include values for all samples in an experimental group.
To identify method-specific biases in accuracy, we calculated the median fold deviation for each gene across dilution replicates within each experimental group. Genes with fewer than three observations were removed. Of the remaining genes, those with median fold deviation in the upper or lower 5%ile were categorized as overestimated and underestimated, respectively. Remaining genes were used as background for enrichment tests for enrichment. For each method, genes within the upper or lower 1%ile
were classified as outlier genes with poor accuracy. Outliers were identified for each experimental group, and then merged across input amounts for each RNA source by taking the union of identified outliers. We repeated outlier identification using computationally ambiguous genes, following the same filtering criteria described above.
To generate density scatter plots of gene read counts in individual dilution replicates, measurements from all 10 pg. dilution replicates for a given method were pooled. The density scatter plots were generated using the R densCols and KernSmooth::bkde2D functions. These functions estimate local density using a binned approximation to a 2 dimensional kernel density with a bivariate Gaussian kernel. log 10 read counts were used. For density scatter plots of average read counts, averages were taken separately for HBR and UHR 10 pg. dilution replicates. Averages for HBR and UHR were pooled before density calculation.
Protocol variations
To evaluate the effect of removing purification of initial cDNA, 12 additional HBR 10 pg. dilution replicates were generated. 6 were generated using the same cDNA protocol as the primary aRNA samples, in which initial cDNA is purified using a MinElute column. 6 were generated without this purification step, with adjusted molarity for aRNA amplification to accommodate the change in reaction volume. Each set of 6 included 3 replicates generated using 13 rounds of PCR amplification during sequencing library preparation and 3 using 15. In this analysis, differences in PCR treatment were ignored.
To evaluate the effect of reducing rounds of cDNA amplification, 5 additional HBR 10 pg. dilution replicates were generated using 2 rounds of IVT amplification (rather than 3). All amplified material was used as input for sequencing library preparation. Additionally, these samples were generated without initial cDNA purification and using 15 rounds of PCR during sequencing library preparation (rather than 13). These data were compared to 3 replicates generated using 3 rounds of aRNA amplification, and otherwise following the same protocol. To evaluate an optimized aRNA protocol, excluding initial cDNA purification and reducing rounds of amplification, the same 5 HBR 10 pg. dilution replicates used to examine the effect of reducing rounds of IVT amplification were compared to the primary HBR 10 pg.
aRNA data.
To examine the effect of ERCC addition, 10 replicates beginning with 10 pg. HBR total RNA were amplified using aRNA. In 5, ERCC spike-in controls were added with reference RNA at a final dilution of 1:4,000,000. Samples generated in ERCC optimization showed evidence of cross-contamination, with counts assigned to ERCC transcripts (total ERCC counts: 892-1,457) at appropriate relative abundances for samples generated without addition of ERCC controls.
The effect of strand-specific sequencing was evaluated by re-quantifying aRNA HBR 10 pg.
samples using strand information. 
MATERIALS & CORRESPONDENCE
Correspondence and material requests should be addressed to Junhyong Kim. amplification of cDNA. aRNA targeted poly-adenylated mRNA by using an oligo-dT T7 primer for initial cDNA synthesis. After generating double-stranded cDNA, molecules were amplified using in vitro transcription with T7 polymerase. This amplification procedure was designed to minimize exponential expansion of errors. cDNA generation and amplification were repeated two additional times before library preparation. SmartSeq Plus targeted total RNA using a mixture of poly-T and randomized primers for initial cDNA synthesis. Full-length transcripts were captured through the template-switching capacity of reverse transcriptase. Double stranded cDNA molecules were amplified using 18 rounds of PCR. All cDNA and amplification reactions were performed on a 96-well Fluidigm C1 chip, intended to reduce experimental variation by performing reactions in small volume. NuGen targeted total RNA through use of proprietary primers for initial cDNA synthesis. Second strand cDNA synthesis was generated using an RNA primer, which was subsequently degraded from the second strand cDNA copy, resulting in linear amplification by DNA replication. This method was designed to minimize exponential amplification of Least-squares regression of log 10 (E) As C for % GC content. (F) As C for strength of local secondary structure. G-J. PCA projection of dilution data on PC 1 and 2. Plots were centered so that bulk UHR or HBR was positioned at the origin. Comparison of dilution replicates generated using modified protocols with control dilution replicates.
Sample information can be found in Table S1 and protocol information in Methods. # genes detected only considers genes observed in bulk HBR or UHR. Kendall correlation was calculated excluding zeros in either sample. Unpaired comparisons were made using Wilcoxon two-way rank sum test for difference in medians. Paired comparisons were made using Wilcoxon two-way rank sign test for difference in medians. The null hypothesis of no difference was rejected at p<0.05. Median difference between groups, with 95% CI, was calculated using the Hodges-Lehman statistic. 
SUPPLMENETAL TABLES
Supplemental tables can be found in attached "supplementalTables.xlsx" file. Table S1 . Control dataset sample identification, protocol information, and RNA sequencing stats Experimental group, protocol information and RNA sequencing statistics for each sample used in primary analyses. Alignment statistics were based on STAR alignment to hg19 and were with respect to reads retained after trimming for primer or poly-A sequences 17 . Table S2 . Computationally unambiguous genes
Genes to which reads can be uniquely assigned. See the Excluded and unambiguous genes section in
Methods for details on classification. Model was fit using randomly selected 90% of 10 pg. data, excluding 17 large influence genes. Fit was evaluated on the remaining 10% of the data. Fit was also evaluated on sequence data that was in silico truncated to 50 base pair single end ("Truncated"), ERCC read counts ("ERCC"), and 100 pg. dilution replicates ("100 pg."). AUC (area under receiver operating characteristic curve) reported as mean values ± 2 Sd. calculated over 10,000 bootstrap samples. AUC (molecules) predicts detection based on number of input molecules alone. See Methods for further details. Genes that are problematic for detection. See Methods for classification of outliers. "Gene set" indicates whether gene is classified as computationally unambiguous (1) or not (2) . "Detected / undetected" indicates whether the gene is unexpectedly observed (D) or unexpectedly unobserved (U).
Table S7. Precision outliers
Genes with standardized residual outside a 99.3% confidence interval, with respect to regression of standard deviation on the mean (see Methods). "Gene set" indicates whether gene is classified as computationally unambiguous (1) or not (2) . Only genes whose mean is within the range of fitted model were included. Column values indicate whether indicate whether the gene standard deviation is unexpectedly low (L) or high (H), given mean. Table S8 . Accuracy outliers Genes were identified as accuracy outliers if its median fold deviation, taken across dilution replicates, was contained in the upper or lower 1%ile of all considered genes (see Methods). Columns labeled by single-cell protocol contain an "H" if a gene was identified as an overestimated outlier, and an "L" if a gene was identified as an underestimated outlier. "Gene set" indicates whether gene is classified as computationally unambiguous (1) or not (2). Table S9 . Optimization dataset sample identification, protocol information, and RNA sequencing stats
As Table S1 for samples used in protocol optimization analyses.
